Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference5 articles.
1. Canafax DM, Gruber SA, Chan GLC, Miles CJ, Matas AJ, et al. The pharmacoeconomics of renal transplantation: increased drug costs with decreased hospitalization costs. Pharmacotherapy 10: 205–210, 1990
2. Foran RM, Brett JL, Wulf PH. Evaluating the cost impact of intravenous antibiotic dosing frequencies. DICP: Annals of Pharmacotherapy 25: 546–552, 1991
3. Mandell LA, Bergeron MG, Ronald AR, Vega C, Harding G, et al. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study. Journal of Infectious Diseases 160: 433–441, 1989
4. Scalley RD, Stuart CC. Is there cost reduction potential for extended half-life cephalosporins? Drug Intelligence and Clinical Pharmacy 20: 975–980, 1986
5. Tanner DJ. Cost containment of reconstituted parenteral antibiotics: personnel and supply costs associated with preparation, dispensing, and administration. Reviews of Infectious Diseases 6: S924–S937, 1984